Reimbursement
People who want to sign up for a policy on healthcare.gov after open enrollment ends may have to prove they qualify for special enrollment.
From sample of 1,202 adults, eight percent of respondents said they or someone in their household had imported a drug at some point.
The group is pressing CMS to make 2018 another transition year, more cybersecurity incentives and to streamline multiple Meaningful Use programs.
Affordable Care Act's fate is coming into question as healthcare organizations move into the new world of value-based care and other advances.
Canadian drugmaker Valeant Pharmaceuticals International Inc. acquired the medication in February 2015 and abruptly doubled the $1,500 retail price.
Almost 70 percent cited cash flow and reimbursement as their top concerns, with similar numbers saying waiting for payment is painful.
The new model was unveiled in March to test whether alternative payments would have given incentives to prescribe less costly drugs. CMS withdrew the proposal after a CMMI review.
Agency predicts the new opportunities will mean 25 percent of clinicians in QPP will be a part of the APMs.
Because of the last-minute rush, Covered California officials have extended the enrollment deadline for coverage that begins Jan. 1.
State-based effort is an Innovation Center initiative for clinicians to participate in advanced alternative payment models under MACRA.